Dr Susan Cleator is a Consultant Clinical Oncologist with extensive experience in breast, colorectal and lymphomatous cancers. She has a specialist interest in early breast cancer and treatment of breast cancer in young women.
After studying medicine at Oxford University and Hospitals, she completed her specialist oncology training at the Charing Cross, Hammersmith, Mount Vernon and The Royal Marsden Hospitals. During this time she spent three years working on her PhD project at the Institute of Cancer Research and Royal Marsden Hospital. Her research focused on identifying a molecular assay for predicting the response of breast cancers to chemotherapy.
Dr Cleator works closely with a multi-disciplinary team at St Mary’s hospital where she is responsible for the chemotherapy and radiotherapy aspect of the patient’s treatment. She is actively involved in research into both breast and colorectal cancers, and has been published in a number of peer-reviewed journals. She is also a member of a number of research groups including the National Cancer Research Institute (NCRI) Breast Cancer Studies Group (BCSG).